10-Q: UHT Q3 Net Income Flat, FFO Up; Medicaid Bill Raises Concerns

Universal Health Realty Income Trust reported flat net income for Q3 2025 but increased FFO, while facing new legislative risks to Medicaid funding and a federal government shutdown.

Summary

• Net income for the third quarter of 2025 was $4.0 million, remaining flat compared to the third quarter of 2024.
• Net income for the nine months ended September 30, 2025, decreased by $1.3 million to $13.3 million, from $14.6 million in the prior year.
• Revenues increased by $808,000 to $25.3 million in Q3 2025 and by $349,000 to $74.7 million for the nine months ended September 30, 2025.
• Funds From Operations (FFO) increased by $908,000 to $12.2 million in Q3 2025, but decreased by $166,000 to $35.9 million for the nine months ended September 30, 2025.
• Basic and diluted earnings per share remained flat at $0.29 for Q3 2025, but decreased to $0.96 (basic) and $0.96 (diluted) for the nine-month period from $1.06 and $1.05, respectively.
• The company declared and paid dividends of $0.740 per share in Q3 2025 and $2.215 per share for the nine months ended September 30, 2025.
• Net cash provided by operating activities increased to $35.5 million for the nine months ended September 30, 2025, from $33.8 million in the prior year.
• A new medical office building, Palm Beach Gardens Medical Plaza I, with an estimated cost of $34 million, is scheduled for completion in Q3 2026, with construction commencing in November 2025.

Sentiment

Score: 4

Explanation: While Q3 net income was flat and FFO saw a slight increase, the nine-month results show a decline in net income and FFO. More importantly, the filing highlights significant new legislative and economic risks, including the "One Big Beautiful Bill Act" impacting Medicaid and the ongoing federal government shutdown, which are expected to unfavorably impact the company's tenants and potentially its own operations. The heavy reliance on UHS also remains a key concern.

Positives

• Net income for Q3 2025 remained stable at $4.0 million compared to Q3 2024.
• Revenues increased by $808,000 in Q3 2025 and by $349,000 for the nine-month period ended September 30, 2025.
• Funds From Operations (FFO) increased by $908,000 to $12.2 million in Q3 2025.
• Net cash provided by operating activities increased by $1.7 million to $35.5 million for the nine months ended September 30, 2025.
• The Credit Agreement maturity date was extended to September 30, 2028, and borrowing capacity increased to $425 million.
• The company was in compliance with all debt covenants as of September 30, 2025.
• A new medical office building development in Palm Beach Gardens, Florida, is underway, with a UHS subsidiary committing to lease approximately 75% of the space.
• Equity in income of unconsolidated LLCs increased to $438,000 in Q3 2025 from $300,000 in Q3 2024, and to $1.215 million for 9M 2025 from $956,000 in 9M 2024.

Negatives

• Net income for the nine months ended September 30, 2025, decreased by $1.3 million to $13.3 million compared to the prior year.
• Diluted earnings per share decreased to $0.96 for the nine months ended September 30, 2025, from $1.05 in the prior year.
• Funds From Operations (FFO) decreased by $166,000 to $35.9 million for the nine months ended September 30, 2025.
• Interest expense, net, increased by $282,000 for the nine months ended September 30, 2025, primarily due to a decrease in interest rate swap income.
• Total Equity decreased from $179.541 million at December 31, 2024, to $158.574 million at September 30, 2025.
• Available borrowing capacity under the Credit Agreement decreased to $67.9 million at September 30, 2025, from $76.1 million at December 31, 2024.
• Unrealized derivative loss on cash flow hedges increased to $4.283 million for the nine months ended September 30, 2025, from $4.055 million in the prior year.

Risks

• A substantial portion of revenues (39-40%) is dependent on one operator, UHS, with risks of non-renewal or purchase options on leases.
• Increased interest rates have significantly raised interest expense, reducing net income and cash flow, and unfavorably impacting access to capital markets.
• The 'One Big Beautiful Bill Act' (July 4, 2025) introduces work/community service requirements for Medicaid, limits provider fees, and eliminates insurance exchange premium tax credits beyond 2025, potentially reducing operator revenues and increasing uncompensated care.
• Tenants face inflationary pressures and staffing shortages, which could impact their ability and willingness to make rental payments.
• Increased competition/capacity and decreases in occupancy and rental rates in certain real estate markets may adversely impact operating results and property values.
• Legislative changes in the healthcare delivery system could materially affect operators' businesses.
• Potential conflicts of interest due to UHS serving as Advisor and officers being UHS employees.
• Unfavorable tax consequences from an inability to complete tax-deferred like-kind exchange transactions.
• Deterioration in national, regional, and local economic conditions, including credit/capital market conditions, could affect funding for growth and debt refinancing.
• Worsening economic conditions could lead to declines in patient volumes, decreased occupancy rates, and negative impacts on bonus rental revenue and lease renewal terms.
• Heightened risk of cybersecurity threats, including ransomware attacks, which could result in significant costs, penalties, litigation, and reputational damage.
• Outcomes of known and unknown litigation, government investigations, and regulatory actions against the company, UHS, or other operators.
• Failure of operators to comply with governmental regulations related to Medicare and Medicaid licensing and certification requirements.
• Real estate market factors, including supply/demand, interest rates, and development of medical office condominiums.
• Impact of severe weather conditions, including hurricanes, on property values and operations.
• Government regulations, including potential reductions to Medicare and Medicaid funding (Budget Control Act of 2011 extended cuts through 2032).
• New tariffs could adversely impact tenants' businesses due to increased costs.
• Issues facing the healthcare industry, such as changes in laws/regulations, unfavorable reimbursement terms, demographic changes, ability to enter managed care agreements, increase in uninsured/self-pay patients, decreasing in-patient admissions, technological/pharmaceutical improvements, and ability to attract/retain qualified medical personnel.
• Uncertainty regarding the future of the Affordable Care Act (ACA) and related subsidies.
• A federal government shutdown, which began on October 1, 2025, due to Congress failing to approve a federal budget for FY2026, could materially unfavorably impact operating results.
• Competition for properties and tenants from other REITs, private investors, banks, and other companies, including UHS.
• Changes in, or inadvertent violations of, tax laws and regulations affecting REIT status.
• Inability to comply with REIT income distribution requirements using only operating cash flow.
• Buy-sell rights within LLC/LP agreements, allowing members to force a sale or purchase of ownership interests.
• Fluctuations in the value of common stock, potentially affected by interest rate changes.

Future Outlook

The company expects to finance all capital expenditures and acquisitions and pay dividends utilizing internally generated funds and additional funds obtained through borrowings under its $425 million Credit Agreement (with $67.9 million available capacity as of September 30, 2025), refinancing existing third-party debt, issuing other long-term debt, and/or issuing equity under its $100 million shelf registration statement. Management believes current capital resources are sufficient to fund operating, investing, and financing requirements for the next twelve months, including maintaining REIT status. However, there is no assurance that financing will be obtainable on acceptable terms or within an acceptable timeframe.

Management Comments

• "We believe that our operating cash flows, cash and cash equivalents, available borrowing capacity under our Credit Agreement and access to the capital markets provide us with sufficient capital resources to fund our operating, investing and financing requirements for the next twelve months, including providing sufficient capital to allow us to make distributions necessary to enable us to continue to qualify as a REIT under Sections 856 to 860 of the Internal Revenue Code of 1986."
• "In determining and monitoring our dividend level on a quarterly basis, our management and Board of Trustees consider many factors in determining the amount of dividends to be paid each period. These considerations primarily include: (i) the minimum required amount of dividends to be paid in order to maintain our REIT status; (ii) the current and projected operating results of our properties, including those owned in LLCs, and; (iii) our future capital commitments and debt repayments, including those of our LLCs."
• "Based upon the information discussed above, as well as consideration of projections and forecasts of our future operating cash flows, management and the Board of Trustees have determined that our operating cash flows have been sufficient to fund our dividend payments."

Industry Context

The healthcare real estate industry is facing significant legislative and economic headwinds. The "One Big Beautiful Bill Act" is poised to reduce Medicaid enrollment and funding, directly impacting the revenues of healthcare operators, including the company's primary tenant, UHS. This could lead to increased uncompensated care and pressure on rental payments. Additionally, the industry continues to grapple with inflationary pressures on personnel and operating costs, as well as staffing shortages, which, while moderating, remain a concern. The ongoing federal government shutdown further exacerbates uncertainty, potentially disrupting healthcare funding and operations. The company's strategy of developing new medical office buildings, such as Palm Beach Gardens Medical Plaza I, aligns with the broader trend of healthcare providers seeking modern, integrated facilities, often on hospital campuses, to enhance patient access and operational efficiency. However, increased competition and fluctuating real estate market conditions, including the development of medical office condominiums, present challenges to occupancy and rental rates.

Comparison to Industry Standards

• The filing does not provide specific comparisons to industry benchmarks or comparable companies/projects. It mentions that the advisory fee computation remained unchanged for 2025 as compared to 2024 and 2023, based on a review against an "industry peer group," but no specific details are provided.
• The company's reliance on a single operator (UHS, 39-40% of revenues) is higher than typical for a diversified REIT, which often aims for lower tenant concentration to mitigate risk.
• The FFO per diluted share of $2.59 for 9M 2025, while a key REIT metric, is not directly compared to industry averages or specific competitors in the filing.
• The company's debt covenants (Total leverage <= 60%, Secured leverage <= 30%, Unencumbered leverage <= 60%, Fixed charge coverage >= 1.50x) are standard for REITs, and the company reports compliance (44.0%, 2.3%, 45.7%, 3.2x respectively as of Sep 30, 2025).

Related Party Transactions

• UHS of Delaware, Inc. (wholly-owned subsidiary of UHS) serves as the company's Advisor under an annually renewable Advisory Agreement.
• The company's officers are all employees of UHS through its wholly-owned subsidiary, UHS of Delaware, Inc.
• Five hospital facilities are leased to wholly-owned subsidiaries of UHS.
• One hospital facility is leased to a joint venture between a wholly-owned subsidiary of UHS and a third party.
• Subsidiaries of UHS are tenants of nineteen medical/office buildings or free-standing emergency departments, either wholly or jointly-owned by the company.
• UHS-related tenants comprised approximately 39% of consolidated revenues during Q3 2025 and 40% during 9M 2025.
• The company has financing receivables from UHS related to the Aiken and Canyon Creek properties, accounted for as a failed sale leaseback.
• UHS has options to renew leases or purchase leased facilities.
• The company entered into a ground lease with a wholly-owned subsidiary of UHS in October 2025 for the development of Palm Beach Gardens Medical Plaza I, with a UHS subsidiary executing a 10-year master flex lease for approximately 75% of the space.
• McAllen Doctor's Center is 100% master leased to McAllen Hospitals, L.P., a wholly-owned subsidiary of UHS.
• Sierra Medical Plaza I has a master flex-lease agreement with a wholly-owned subsidiary of UHS for 34% of the rentable square feet.
• The company is the lessee on thirteen ground leases with subsidiaries of UHS.
• Advisory fees paid to UHS were approximately $1.4 million for Q3 2025 and $4.2 million for 9M 2025.
• UHS owned 5.7% of the company's outstanding shares as of September 30, 2025.
• The company provided a $327,000 loan to a third-party partner of an unconsolidated LLC, which is scheduled to be repaid in Q4 2025.

Stakeholder Impact

• Shareholders: Potential negative impact on share value due to declining nine-month net income and FFO, increased interest expense, and significant new legislative and economic risks (Medicaid changes, federal shutdown). Dividends per share increased slightly, but future dividend levels are subject to operating results and capital commitments.
• Tenants (especially UHS subsidiaries): Expected reduction in revenues and increased uncompensated care due to the "One Big Beautiful Bill Act" affecting Medicaid and insurance exchange tax credits. Ongoing inflationary pressures and staffing shortages could impact their operating results and ability to make rental payments. The federal government shutdown could also materially unfavorably impact their operations.
• Employees (UHS employees serving as UHT officers): No direct impact mentioned, but overall company performance and the health of UHS could indirectly affect compensation or job security.
• Creditors: The company remains in compliance with all debt covenants, and its Credit Agreement maturity was extended, which is positive. However, increased interest rates and potential economic downturns could affect future debt servicing capacity.
• Customers (patients of facilities): The "One Big Beautiful Bill Act" could limit Medicaid enrollment and reduce access to care for some individuals, potentially increasing uncompensated care at the facilities.

Next Steps

• Construction of Palm Beach Gardens Medical Plaza I is expected to commence in November 2025, with completion scheduled for Q3 2026.
• The third-party partner's net share of the Grayson Properties II loan repayment ($327,000) is scheduled to be repaid to the company, with interest, during the fourth quarter of 2025.
• The company will continue to market the vacant Chicago, Illinois, and Evansville, Indiana properties to third parties.
• Management and the Board of Trustees will continue to monitor and determine future dividend levels based on REIT status requirements, operating results, and future capital commitments.
• The company is evaluating the impact of ASU 2024-03 on its financial statement disclosures, effective for fiscal years beginning after December 15, 2026.

Key Dates

Recommendation

The company shows mixed financial results with flat Q3 net income but declining nine-month net income and FFO. While operating cash flow is strong and debt covenants are met, significant new legislative risks (Medicaid changes, federal shutdown) and ongoing industry challenges (inflation, staffing, competition) create substantial uncertainty for future performance and tenant stability. The high reliance on UHS also presents a concentration risk. The new MOB development is a positive, but its impact is long-term. Given the current headwinds and uncertainties, a "hold" recommendation is appropriate, suggesting investors monitor the impact of the new legislation and economic conditions on the company's tenants and financial results before making further investment decisions.

Keywords

REIT, Healthcare Real Estate, Medical Office Buildings, Hospitals, Behavioral Health, SEC Filing, 10-Q, Financial Results, Earnings, Funds From Operations, Dividends, Debt, Interest Rates, Medicaid, ACA, UHS, Real Estate Investment Trust, Quarterly Report, Healthcare Facilities, Property Development, Lease Revenue, Corporate Governance, Risk Factors, Capital Structure, Financial Performance